Drug-coating Balloon Treatment in Coronary Artery Disease

Drug-coating Balloon Treatment in Coronary Artery Disease: a Prospective, Multicenter, Registry Study (ULTIMATE-DCB)

Drug-coated balloon (DCB) is an alternative choice for patients with coronary artery disease (CAD). This study is to investigate the efficacy and safety of DCB treatment in patients with CAD.

This is a prospective, multi-center, registry to enroll patients undergoing DCB treatment.

All subjects undergoing DCB treatment will be enrolled in this study without strict inclusion and exclusion criteria. Data and images will be collected during the index procedure, and at the clinical and angiographic follow-up.

Inclusion Criteria:

• Patients suitable for DCB treatment

Exclusion Criteria:

• Pregnancy
• Contraindications to contrast media, antiplatelet therapy, or paclitaxel
• Expected life less than 12 months
• Cardiac shock